Page last updated: 2024-10-25

ciprofloxacin and Bacterial Skin Diseases

ciprofloxacin has been researched along with Bacterial Skin Diseases in 73 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research Excerpts

ExcerptRelevanceReference
"Ciprofloxacin or doxycycline is recommended for antimicrobial prophylaxis and treatment of adults and children with Bacillus anthracis infection associated with the recent bioterrorist attacks in the United States."3.71Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. ( , 2001)
"While being treated with corticosteroids and methotrexate for rheumatoid arthritis, a 63-year-old man developed livid nodules on his lower arms, hands and feet, as well as fever, necrotizing skin ulcers and rupture of a finger extensor tendon."3.71[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis]. ( Böcher, W; Galle, PR; Märker-Hermann, E, 2002)
" Drug-related adverse events were reported by 8."2.69A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections. ( Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA, 1998)
"Anthrax is still an endemic disease in some countries in the world and has become a re-emerging disease in western countries with recent intentional outbreak."2.46A review of cutaneous anthrax and its outcome. ( Alp, E; Doganay, M; Metan, G, 2010)
"Cutaneous diphtheria is a rare infection in the United States."2.44Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections. ( English, JC; Lee, PL; Lemos, B; O'Brien, SH; Zirwas, MJ, 2007)
"In a mouse skin wound infection model, F6 was equipotent to the antibiotic fusidic acid in reducing MRSA burden."1.48N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria. ( Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO, 2018)
"Anthrax is an endemic disease in developing countries."1.43Cutaneous anthrax: evaluation of 28 cases in the Eastern Anatolian region of Turkey. ( Akbulut, A; Demir, B; Denk, A; Ozden, M; Tartar, AS, 2016)
"Cutaneous anthrax is an infection of the skin caused by Bacillus anthracis."1.40Cutaneous anthrax in a school teacher. ( Alam, MA; Baidya, NR; Kamal, MM; Mostafa, SM; Nandi, AK; Rahman, F; Uddin, MJ, 2014)
"Anthrax is a rare disease caused by Bacillus anthracis."1.39Evaluation of cutaneous palpebral anthrax. ( Ari, S; Dal, T; Dayan, S; Dursun, B; Kaya, S; Kortak, MZ; Tekin, R, 2013)
"Anthrax is occasionally encountered by U."1.39Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system. ( Krivda, S; Norton, SA; Pace, S; Steigelman, D, 2013)
"Tularemia is a worldwide zoonosis caused by Francisella tularensis."1.38Cavitary pneumonia and skin lesions. ( Alvela-Suárez, L; Belhassen-Garcia, M; Carpio-Pérez, A; Fraile-Alonso, Mdel C; Pardo-Lledias, J; Velasco-Tirado, V, 2012)
"Anthrax was suspected primarily based on cutaneous manifestations of typical non-tender ulcer with black eschar, with or without oedema, and a history of butchering, or dressing/washing of cattle/goat or their meat."1.38Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital. ( Ahmed, SS; Akhtaruzzaman, SM; Anwar, KS; Khan, MA; Salam, MA; Siddiqui, MA, 2012)
"If left untreated, cutaneous anthrax may progress in 5 to 20% of cases to septicaemia with potentially lethal central nervous system involvement."1.35[Cutaneous anthrax: seven cases]. ( Alifadl, A; Azouzi, AI; Bjani, L; Chraibi, H; Gaamouche, K; Haouach, K; Kaidi, A; Khalidi, TE; Mountasser, A, 2009)
"Incidence of anthrax is diminishing in developed countries; however, it remains a public health problem in developing countries, especially those whose main source of income is farming."1.35Characteristics of cutaneous anthrax in Turkey. ( Baykam, N; Celikbas, A; Dokuzoguz, B; Eren, S; Ergonul, O; Eroglu, M; Ulu, A, 2009)
"Although cutaneous anthrax is usually self-limiting, complications may arise in untreated cases."1.33An unusually extensive case of cutaneous anthrax in a patient with type II diabetes mellitus. ( Ayaslioglu, E; Beygo, B; Erkek, E; Ozluk, U, 2005)
" This report updates the investigation of these cases and describes adverse events associated with antimicrobial prophylaxis."1.31Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. ( , 2001)
" During October 26-November 6, 2001, an epidemiologic evaluation to detect adverse events associated with antimicrobial prophylaxis was conducted among 8,424 postal employees who had been offered antimicrobial prophylaxis for 60 days in New Jersey (NJ), New York City (NYC), and one postal facility in the District of Columbia (DC)."1.31Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001. ( , 2001)
"Ciprofloxacin was also tested against Gram-negative isolates."1.31Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. ( Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL, 2002)

Research

Studies (73)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's14 (19.18)18.2507
2000's36 (49.32)29.6817
2010's22 (30.14)24.3611
2020's1 (1.37)2.80

Authors

AuthorsStudies
Amsler, KM1
Davies, TA1
Shang, W1
Jacobs, MR1
Bush, K1
Opoku-Temeng, C1
Naclerio, GA1
Mohammad, H1
Dayal, N1
Abutaleb, NS1
Seleem, MN1
Sintim, HO1
Kibar Ozturk, M1
Bartolomé-Álvarez, J1
Solves-Ferriz, V1
Reisfeld, L1
Ikuta, CY1
Ippolito, L1
Silvatti, B1
Ferreira Neto, JS1
Catão-Dias, JL1
Rosas, FCW1
Neto, JA1
da Silva, VMF1
Tekin, R1
Ari, S1
Dal, T1
Kaya, S1
Kortak, MZ1
Dursun, B1
Dayan, S1
Brauns, B1
Schön, MP1
Mempel, M1
Pace, S1
Steigelman, D1
Norton, SA1
Krivda, S1
Turhanoğlu, NM1
Bayındır Bilman, F1
Kutlu Yürüker, S1
Cowart, DW1
Moradi, BN1
Arora, NS1
Chatterjee, K1
Chaudhuri, A1
Chatterjee, G1
Parlak, E2
Parlak, M2
Atli, SB1
Nandi, AK1
Kamal, MM1
Alam, MA1
Rahman, F1
Uddin, MJ1
Baidya, NR1
Mostafa, SM1
Denk, A1
Tartar, AS1
Ozden, M1
Demir, B1
Akbulut, A1
Flinn, A1
McDermott, M1
Butler, KM1
Tan, M1
Lee, JS1
Pan, JY1
Chraibi, H1
Haouach, K1
Azouzi, AI1
Gaamouche, K1
Kaidi, A1
Khalidi, TE1
Alifadl, A1
Bjani, L1
Mountasser, A1
Grocholski, AS1
Delage, M1
Samimi, M1
Maruani, A1
Difonzo, EM1
Campanile, GL1
Vanzi, L1
Lotti, L1
Baykam, N1
Ergonul, O1
Ulu, A1
Eren, S1
Celikbas, A1
Eroglu, M1
Dokuzoguz, B1
Castro-Silva, AN1
Freire, AO1
Grinbaum, RS1
Elmor de Araújo, MR1
Abensur, H1
Araújo, MR1
Romão, JE1
Sampaio, JL1
Noronha, IL1
Doganay, M2
Metan, G2
Alp, E1
Duncan, KO1
Smith, TL1
Kay, MK1
Perti, TR1
Duchin, JS1
Belhassen-Garcia, M1
Velasco-Tirado, V1
Alvela-Suárez, L1
Fraile-Alonso, Mdel C1
Carpio-Pérez, A1
Pardo-Lledias, J1
Kayabas, U1
Karahocagil, MK1
Ozkurt, Z1
Bayindir, Y1
Kalkan, A1
Akdeniz, H1
Simpson, AJ1
Siddiqui, MA1
Khan, MA1
Ahmed, SS1
Anwar, KS1
Akhtaruzzaman, SM1
Salam, MA1
Coutinho, AS1
de Morais, OO1
Gomes, CM1
de Oliveira Carneiro da Motta, J1
Rao, J1
Golden, TA1
Fitzpatrick, RE1
Marzano, AV1
Mercogliano, M1
Borghi, A1
Facchetti, M1
Caputo, R1
Iakovlev, VP2
Svetukhin, AM1
Blatun, LA1
Ukhin, SA1
Godyn, JJ1
Reyes, L1
Siderits, R1
Hazra, A1
Fragoulis, KN1
Klouvas, GD1
Falagas, ME1
Erkek, E1
Ayaslioglu, E1
Beygo, B1
Ozluk, U1
Yetkin, MA1
Erdinc, FS1
Bulut, C1
Tulek, N1
Qadir, SN1
Raza, N1
Rahman, SB1
Lee, PL1
Lemos, B1
O'Brien, SH1
English, JC1
Zirwas, MJ1
Yu, Y1
Cheng, AS1
Wang, L1
Dunne, WM1
Bayliss, SJ1
Roé, E1
Barnadas, MA1
Bergua, P1
Sancho, F1
Matas, L1
Paredes, R1
Pujol, J1
Alomar, A1
Lorian, V1
Pavletich, K1
Zahid, MA1
Klotz, SA1
Goldstein, E1
Bartholomew, W1
Delaporte, E1
Savage, C1
Alfandari, S1
Piette, F1
Leclerc, H1
Bergoend, H1
Clark, JA1
Margolis, DM1
Liu, HH1
Bolash, NK1
McAnany, ME1
Lynch, RA1
Hachem, R1
Raad, I1
Rolston, KV1
Whimbey, E1
Katz, R1
Tarrand, J1
Libshitz, H1
Braun, H1
Autenrieth, IB1
Schuster, V1
Ewald, J1
Harmsen, D1
Kreth, HW1
Nicodemo, AC1
Robledo, JA1
Jasovich, A1
Neto, W1
Niang, M1
Debat Zoguereh, D1
Badiaga, S1
Brouqui, P1
Krumpe, PE1
Cohn, S1
Garreltes, J1
Ramirez, J1
Coulter, H1
Haverstock, D1
Echols, R1
Martinez, JG1
Semret, M1
Koromihis, G1
MacLean, JD1
Libman, M1
Ward, BJ1
Ghosh, SK1
Wolfe, J1
Turenne, C1
Alfa, M1
Harding, G1
Thibert, L1
Kabani, A1
Lemonick, MD1
SoRelle, R1
Gallagher, TC1
Strober, BE1
Blondeau, JM1
Tutrone, WD1
Scheinfeld, NS1
Weinberg, JM1
Böcher, W1
Galle, PR1
Märker-Hermann, E1
Celia, F1
Pelak, BA1
Bartizal, K1
Woods, GL1
Gesser, RM1
Motyl, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients[NCT00050310]200 participants (Anticipated)Observational2002-10-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

8 reviews available for ciprofloxacin and Bacterial Skin Diseases

ArticleYear
A review of cutaneous anthrax and its outcome.
    Journal of infection and public health, 2010, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Amoxicillin; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; D

2010
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2004, Volume: 49, Issue:8-9

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastro

2004
Cutaneous anthrax: conservative or surgical treatment?
    Advances in skin & wound care, 2005, Volume: 18, Issue:3

    Topics: Anthrax; Anti-Bacterial Agents; Biopsy; Bioterrorism; Ciprofloxacin; Diagnosis, Differential; Doxycy

2005
Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections.
    Cutis, 2007, Volume: 79, Issue:5

    Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium diphtheriae;

2007
[Use of ciprofloxacin in the treatment and prevention of surgical infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1999, Volume: 44, Issue:7

    Topics: Anti-Infective Agents; Bacterial Infections; Bone Diseases, Infectious; Ciprofloxacin; Humans; Joint

1999
The role of fluoroquinolones in skin and skin structure infections.
    American journal of clinical dermatology, 2002, Volume: 3, Issue:1

    Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Micr

2002
Cutaneous anthrax: a concise review.
    Cutis, 2002, Volume: 69, Issue:1

    Topics: Administration, Oral; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Doxycycl

2002
Cutaneous anthrax: an overview.
    Dermatology nursing, 2002, Volume: 14, Issue:2

    Topics: Adult; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; Bioterrorism; Chil

2002

Trials

6 trials available for ciprofloxacin and Bacterial Skin Diseases

ArticleYear
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bac

2008
Naturally occurring cutaneous anthrax: antibiotic treatment and outcome.
    Chemotherapy, 2012, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Fe

2012
Paederus dermatitis in Sierra Leone.
    Dermatology online journal, 2006, Dec-10, Volume: 12, Issue:7

    Topics: Administration, Oral; Administration, Topical; Adult; Animals; Anti-Bacterial Agents; Cetirizine; Ci

2006
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
    Drugs, 1995, Volume: 49 Suppl 2

    Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug

1995
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
    International journal of clinical practice, 1998, Volume: 52, Issue:2

    Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Huma

1998
Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43 Suppl A

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Ag

1999

Other Studies

59 other studies available for ciprofloxacin and Bacterial Skin Diseases

ArticleYear
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
    European journal of medicinal chemistry, 2018, Jul-15, Volume: 155

    Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug

2018
Suspected cutaneous anthrax in rural areas.
    Journal of infection in developing countries, 2019, 02-28, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Female; Humans; Male;

2019
[Increase in methicillin-resistant and ciprofloxacin-susceptible Staphylococcus aureus in osteoarticular, skin and soft tissue infections].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2020, Volume: 33, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Joint Diseases; Meth

2020
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis.
    Diseases of aquatic organisms, 2018, Mar-05, Volume: 127, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Male; Mycobacterium fortuitum; Mycoba

2018
Evaluation of cutaneous palpebral anthrax.
    Cutaneous and ocular toxicology, 2013, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anthrax; Anti-Bacterial Agents; Bacillus ant

2013
Papulopustular eruption after holiday in a 44-year-old man. Whirlpool dermatitis (pseudomonas folliculitis).
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2013, Volume: 11, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Baths; Ciprofloxacin; Diagnosis, Differential; Folliculitis; Humans;

2013
Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system.
    Military medicine, 2013, Volume: 178, Issue:8

    Topics: Adolescent; Afghan Campaign 2001-; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin

2013
[Four cases of cutaneous anthrax in Diyarbakir, Turkey].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:3

    Topics: Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cattle; Ciprofloxacin; Diagnosis, Diffe

2013
A 50-year-old man with blistering skin lesions on both feet.
    BMJ case reports, 2013, Nov-01, Volume: 2013

    Topics: Blister; Ciprofloxacin; Disease Progression; Follow-Up Studies; Hawaii; Humans; Male; Middle Aged; N

2013
Charbon: a classical presentation.
    International journal of dermatology, 2014, Volume: 53, Issue:7

    Topics: Adult; Agriculture; Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Hand Dermatoses; Humans; Male; Oc

2014
Unusual cause of fatal anthrax meningitis.
    Cutaneous and ocular toxicology, 2015, Volume: 34, Issue:1

    Topics: Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Meningitis; Middle Age

2015
Cutaneous anthrax in a school teacher.
    Mymensingh medical journal : MMJ, 2014, Volume: 23, Issue:2

    Topics: Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Faculty; Humans; Male; Middle Aged; Skin Diseases, Ba

2014
Cutaneous anthrax: evaluation of 28 cases in the Eastern Anatolian region of Turkey.
    Cutaneous and ocular toxicology, 2016, Volume: 35, Issue:3

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anthrax; Anti-Bacterial Agents; Bacillus anthracis

2016
A Child With Septic Shock and Purpura.
    JAMA pediatrics, 2016, Volume: 170, Issue:4

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Female; Hu

2016
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.
    Annals of the Academy of Medicine, Singapore, 2016, Volume: 45, Issue:10

    Topics: Actinomycosis; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agen

2016
[Cutaneous anthrax: seven cases].
    Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:1

    Topics: Adolescent; Adult; Animals; Anthrax; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Male; Mid

2009
[Acute dermohypodermitis of the right leg (S. putrefaciens) after sea bathing].
    Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:1

    Topics: Acute Disease; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Leg Ulcer; Male; Oceans and Seas;

2009
Mesotherapy and cutaneous Mycobacterium fortuitum infection.
    International journal of dermatology, 2009, Volume: 48, Issue:6

    Topics: Adult; Aesculus; Anti-Infective Agents; Biopsy; Ciprofloxacin; Cosmetic Techniques; Female; Humans;

2009
Characteristics of cutaneous anthrax in Turkey.
    Journal of infection in developing countries, 2009, Sep-15, Volume: 3, Issue:8

    Topics: Anthrax; Anti-Infective Agents; Ciprofloxacin; Developing Countries; Drug Therapy, Combination; Fema

2009
Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment.
    Transplant infectious disease : an official journal of the Transplantation Society, 2011, Volume: 13, Issue:1

    Topics: Acupuncture Therapy; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Humans; Immunocompromised

2011
Primary cutaneous infection with Bacillus megaterium mimicking cutaneous anthrax.
    Journal of the American Academy of Dermatology, 2011, Volume: 65, Issue:2

    Topics: Adult; Anthrax; Bacillus megaterium; Ciprofloxacin; Diagnosis, Differential; Female; Follow-Up Studi

2011
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.
    Emerging infectious diseases, 2011, Volume: 17, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Contact Tracing; Drug Therapy, Combinat

2011
Cavitary pneumonia and skin lesions.
    Respiratory care, 2012, Volume: 57, Issue:3

    Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Female; H

2012
Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital.
    BMC research notes, 2012, Aug-28, Volume: 5

    Topics: Adolescent; Adult; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bangladesh; Cattle;

2012
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
    Infection, 2013, Volume: 41, Issue:2

    Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacteri

2013
Atypical mycobacterial infection following blepharoplasty and full-face skin resurfacing with CO2 laser.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:8

    Topics: Anti-Infective Agents; Blepharoplasty; Ciprofloxacin; Female; Humans; Laser Therapy; Middle Aged; My

2002
Cutaneous infection caused by Salmonella typhi.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2003, Volume: 17, Issue:5

    Topics: Adult; Bacteremia; Biopsy, Needle; Ciprofloxacin; Endemic Diseases; Female; Follow-Up Studies; Human

2003
Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae.
    The American journal of medicine, 2005, Volume: 118, Issue:8

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Facial Dermatos

2005
An unusually extensive case of cutaneous anthrax in a patient with type II diabetes mellitus.
    Clinical and experimental dermatology, 2005, Volume: 30, Issue:6

    Topics: Aged; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Diabetes Mellitus, Type 2;

2005
Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey.
    Saudi medical journal, 2006, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Agriculture; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Baci

2006
Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa.
    Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks;

2007
Ano-genital granulomatosis treated with ciprofloxacin.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:1

    Topics: Adult; Anti-Infective Agents; Anus Diseases; Ciprofloxacin; Female; Genital Diseases, Female; Granul

2009
Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Drugs under experimental and clinical research, 1994, Volume: 20, Issue:5

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial I

1994
Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:6

    Topics: Aged; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity

1994
[Mycobacterium kansasii cutaneous infection].
    Annales de dermatologie et de venereologie, 1993, Volume: 120, Issue:4

    Topics: Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Middle Aged; Minocycline; Mycobacterium In

1993
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16, Issue:4

    Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; D

1993
Cutaneous and pulmonary infections caused by Mycobacterium vaccae.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:1

    Topics: Aged; Animals; Anti-Bacterial Agents; Cattle; Ciprofloxacin; Humans; Male; Middle Aged; Minocycline;

1996
[Ciprofloxacin in treatment of common bacterial skin infections. Results of an open study in general practice].
    Fortschritte der Medizin, 1996, Feb-20, Volume: 114, Issue:5

    Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug A

1996
An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 23, Issue:3

    Topics: Adoptive Transfer; Agammaglobulinemia; Anti-Infective Agents; Campylobacter Infections; Campylobacte

1996
[Painful nodular lesions].
    La Revue de medecine interne, 1998, Volume: 19, Issue:9

    Topics: Adult; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Lymph Nodes; Male; Mycobact

1998
Pacemaker pocket infection.
    Pacing and clinical electrophysiology : PACE, 1999, Volume: 22, Issue:4 Pt 1

    Topics: Acinetobacter Infections; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Pacemaker, Artif

1999
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
    The American journal of tropical medicine and hygiene, 1999, Volume: 61, Issue:5

    Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxa

1999
A rare infection caused by Chryseomonas luteola.
    The Journal of infection, 2000, Volume: 41, Issue:1

    Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Ciprofloxacin; Diabetes C

2000
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.
    Journal of clinical microbiology, 2000, Volume: 38, Issue:10

    Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Clarithromycin; DNA, Ribosomal; Drug Therapy, C

2000
Anthrax. Deadly delivery.
    Time, 2001, Oct-22, Volume: 158, Issue:18

    Topics: Anthrax; Anti-Infective Agents; Bioterrorism; Ciprofloxacin; Humans; Respiratory Tract Infections; S

2001
Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    MMWR. Morbidity and mortality weekly report, 2001, Oct-19, Volume: 50, Issue:41

    Topics: Adult; Aged; Anthrax; Anti-Infective Agents; Bacillus anthracis; Bioterrorism; Ciprofloxacin; Female

2001
Attempts to stem Anthrax fears stumble.
    Circulation, 2001, Nov-06, Volume: 104, Issue:19

    Topics: Adrenal Cortex Hormones; Anthrax; Bacillus anthracis; Bioterrorism; Centers for Disease Control and

2001
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    MMWR. Morbidity and mortality weekly report, 2001, Oct-26, Volume: 50, Issue:42

    Topics: Adult; Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Chi

2001
Cutaneous Bacillus anthracis infection.
    The New England journal of medicine, 2001, Nov-29, Volume: 345, Issue:22

    Topics: Adult; Anthrax; Anti-Infective Agents; Arm; Bacillus anthracis; Ciprofloxacin; Humans; Male; New Yor

2001
Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    MMWR. Morbidity and mortality weekly report, 2001, Nov-09, Volume: 50, Issue:44

    Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa

2001
Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.
    MMWR. Morbidity and mortality weekly report, 2001, Nov-16, Volume: 50, Issue:45

    Topics: Adult; Amoxicillin; Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bioterrorism; Breast Fee

2001
From the Centers for Disease Control and Prevention. Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
    JAMA, 2001, Nov-07, Volume: 286, Issue:17

    Topics: Adult; Aged; Anthrax; Anti-Infective Agents; Bacillus anthracis; Bioterrorism; Ciprofloxacin; Female

2001
From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    JAMA, 2001, Nov-14, Volume: 286, Issue:18

    Topics: Adult; Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Chi

2001
From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
    JAMA, 2001, Nov-28, Volume: 286, Issue:20

    Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa

2001
From the Centers for Disease Control and Prevention. Recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.
    JAMA, 2001, Dec-05, Volume: 286, Issue:21

    Topics: Adult; Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bioterrorism; Breast Feeding; Child;

2001
From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    JAMA, 2001, Dec-19, Volume: 286, Issue:23

    Topics: Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa

2001
Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
    MMWR. Morbidity and mortality weekly report, 2001, Nov-30, Volume: 50, Issue:47

    Topics: Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa

2001
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].
    Deutsche medizinische Wochenschrift (1946), 2002, Apr-05, Volume: 127, Issue:14

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Antitubercular Agents; Arthritis

2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
    Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:2

    Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial

2002